comparemela.com

Latest Breaking News On - நோர்வே பதிவு ஆஃப் வணிக நிறுவனங்கள் - Page 4 : comparemela.com

Nordic Nanovector ASA - Share capital increase registered

Nordic Nanovector ASA - Share capital increase registered Company ) private placement of new shares (the Private Placement ). The share capital increase pertaining to the 15,878,122 new shares, each with a nominal value of NOK 0.20, to be issued in the Private Placement (the New Shares ) has been registered in the Norwegian Register of Business Enterprises (the NRBE ) on 25 February 2021, and the Company s share capital has been increased with NOK 3,175,624,40 through the issuance of the New Shares. The New Shares are admitted to listing and made tradable on the Oslo Stock Exchange following this stock exchange announcement. Following registration of the share capital increase related to the New Shares in the NRBE, the Company has an issued share capital of NOK 19,053,746.80, divided into 95,268,734 shares, each with a par value of NOK 0.20. Each share represents one vote in the Company s general meeting.

Nordic Nanovector - Private placement successfully completed

Nordic Nanovector - Private placement successfully completed Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN OSLO, Norway, Feb. 23, 2021 /PRNewswire/ Reference is made to the stock exchange release from Nordic Nanovector ASA (OSE: NANO) ( Nordic Nanovector or the Company ), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics, published on 23 February 2021 regarding the contemplated private placement of new shares in the Company.

Nordic Nanovector launches a private placement of new shares

Nordic Nanovector launches a private placement of new shares Nordic Nanovector ASA (OSE: NANO) ( Nordic Nanovector or the Company ), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics, announces the launch of a private placement of new shares (the Offer Shares ) representing up to approximately 20% of the outstanding share capital of the Company at this date (the Private Placement ). The Company has engaged ABG Sundal Collier ASA, Carnegie AS and DNB Markets, a part of DNB Bank ASA as Joint Global Coordinators and Joint Bookrunners (collectively referred to as the

Aker ASA: Aker Horizons - Private Placement and convertible bond issue successfully placed

Aker ASA: Aker Horizons - Private Placement and convertible bond issue successfully placed NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OSLO, Norway, Jan. 28, 2021 /PRNewswire/ Reference is made to the stock exchange announcement by Aker ASA on 27 January 2021 regarding Aker Horizon AS ( Aker Horizons or the Company ) contemplated (i) private placement of new shares in the Company raising up to approximately NOK 4,150 million in gross proceeds (the Private Placement ) and (ii) a convertible bond issue of NOK 1,500 million (the Convertible Bond Issue ). The Company is pleased to announce that the Private Placement and the Convertible Bond Issue have been successfully placed.

AKER ASA: Aker Horizons - Contemplated private placement and convertible bond issue

AKER ASA: Aker Horizons - Contemplated private placement and convertible bond issue OSLO, Norway, Jan. 27, 2021 /PRNewswire/ Reference is made to the previous stock exchange announcement made by Aker ASA ( Aker ) on 19 January 2021 regarding the acquisition of Mainstream Renewable Power (the Acquisition ), a private placement (the Private Placement ) and a listing on Euronext Growth Oslo (the Listing , and together with the Private Placement, the IPO ) of Aker Horizons with a plan for a subsequent transfer of the listing to the Oslo Stock Exchange within 12 months. Aker Horizons AS ( Aker Horizons or the Company ), the newly established parent company of the Aker Horizons group, contemplates a private placement of new shares in the Company (the Private Placement) to raise gross proceeds of up to approximately NOK 4,150 million and (ii) a convertible bond issue of NOK 1,500 million (the Convertible Bond Issue ). Aker will through its wholly-owned subsidiary Aker Capital AS

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.